ClinicalTrials.govpublic full text
Long-Term Organ Damage: Anifrolumab Versus Real-World Standard of Care in Adult Patients With Active Systemic Lupus Erythematosus
long-term organ damage in adult patients with active systemic lupus erythematosus, anifrolumab, active systemic lupus erythematosus, long-term organ damage, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 883638
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.